Most cancer centres don't have a decision-making problem. The people in the tumour board room are experienced, the discussion is usually good, and the panel reaches a sensible plan. The trouble comes before and after the meeting.
Before the meeting, the case arrives incomplete. The pathology report sits in one system, the latest scan is on a disc or a phone, and the question the referring doctor actually wants answered isn't written down anywhere. Ten minutes of a busy meeting go on finding things that should already have been on screen.
Afterwards, the decision often lives in someone's notes. If the minutes say 'neoadjuvant chemotherapy, then reassess', who checks that the patient started on time? Who notices when the plan changed in week six, and why? When the patient comes back eighteen months later, can anyone see what the panel was weighing up?
None of this is a failure of clinicians. It's what happens when the record is split across systems that were never built to carry a case from start to finish.
What a continuous record looks like
We built OncoSync around one idea: a case should be a single record that moves with the patient, from workup and investigations to the multidisciplinary team (MDT), and on through treatment and follow-up. In practice, that means four things.
The question comes with the case. When a case goes to MDT, the reason is tagged. It might be a radiology–pathology correlation, a sequencing decision or a treatment plan that needs agreeing. The panel answers the question that was actually asked.
The evidence is already there. Staging, receptor status and investigation results are part of the case, not attachments someone has to hunt for.
Decisions carry their reasons. When the panel decides, the decision is recorded along with the reasoning and the guideline reference behind it. If someone later departs from it, that's recorded too, with a written reason, as a new version rather than an overwrite.
The plan flows into treatment. The agreed plan becomes the regimen, the cycles and the follow-up schedule, so the people delivering care are working from what was decided.
What it doesn't do
It doesn't make the decision. OncoSync surfaces guideline-referenced options and flags gaps, but the treating clinicians decide, and responsibility stays with them. We think that's the right line for clinical software, and we've designed the product around it.
It isn't a substitute for good meeting discipline either. A structured record makes a well-run tumour board faster. It can't rescue one where cases are routinely presented without preparation.
A five-minute test
If you're looking at your own MDT process, try this. Pick five patients discussed three months ago. For each one, answer three questions: what did the panel answer, what did it decide and why, and is the patient on that plan today? If that takes more than a few minutes per patient, the problem is the record, not the people.